UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
April 23, 2004
BIOSOURCE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-21930 77-0340829
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
542 Flynn Road, Camarillo, California 93012
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (805) 987-0086
Item 7. - Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Statements. None.
(b) Pro Forma Financial Information. None.
(c) Exhibits.
99.1 Press Release dated April 23, 2004, published by BioSource
International, Inc. (the "Company").
Item 12. Results of Operations and Financial Condition.
On April 23, 2004, the Company issued a press release regarding its
financial results for the first quarter ended March 31, 2004. A copy of the
press release is attached hereto as Exhibit 99.1 and is incorporated herein by
this reference.
The information in this report shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or the
Securities Exchange Act of 1934, except as shall be expressly set forth by
specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOSOURCE INTERNATIONAL, INC.
April 23, 2004 /s/ Charles C. Best
-----------------------------
Charles C. Best
Chief Financial Officer
EXHIBIT INDEX
Exhibit Number Description
99.1 Press Release dated April 23, 2004, published by
the Company.